薬剤比較
Dapagliflozin vs Vildagliptin
Compare Dapagliflozin and Vildagliptin for type 2 diabetes: SGLT2 vs DPP-4 inhibitors. Key differences in efficacy, CV/renal benefits, and side effects.
このページには比較できる項目がありません。
臨床的背景
Patients with type 2 diabetes choosing between SGLT2 and DPP-4 inhibitors, especially with cardiovascular or renal comorbidities.
結論
Dapagliflozin may be preferred for added heart and kidney benefits, while Vildagliptin suits those needing straightforward glycemic control.
すべての薬剤比較